No time for prudence when momentum and potential turnaround in sentiment is bubbling. Spend as required
- Forums
- ASX - By Stock
- NEU
- Ann: Appendix 4C - quarterly
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.57%
!
$13.18

Ann: Appendix 4C - quarterly, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.18 |
Change
0.330(2.57%) |
Mkt cap ! $1.626B |
Open | High | Low | Value | Volume |
$13.15 | $13.28 | $12.92 | $2.775M | 212.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 158 | $13.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.19 | 156 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 825 | 13.190 |
4 | 187 | 13.180 |
5 | 533 | 13.170 |
11 | 1609 | 13.160 |
5 | 1308 | 13.150 |
Price($) | Vol. | No. |
---|---|---|
13.200 | 36 | 3 |
13.210 | 221 | 5 |
13.220 | 494 | 3 |
13.230 | 508 | 3 |
13.240 | 1237 | 4 |
Last trade - 11.13am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online